Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yuxiang Wang; Xian Li; Xueling Liu; Yi Chen; Chunhao Yang; Cun Tan; Bobo Wang; Yiming Sun; Xi Zhang; Yinglei Gao; Jian Ding; Linghua Meng

doi:10.20892/j.issn.2095-3941.2019.0401

OtherErratum

Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding and Linghua Meng

Cancer Biology & Medicine November 2019, 16 (4) 836; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0401

Yuxiang Wang

1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2University of Chinese Academy of Sciences, Beijing 100049, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xian Li

1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xueling Liu

1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2University of Chinese Academy of Sciences, Beijing 100049, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yi Chen

2University of Chinese Academy of Sciences, Beijing 100049, China

3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chunhao Yang

4Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200120, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cun Tan

4Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200120, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bobo Wang

1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yiming Sun

2University of Chinese Academy of Sciences, Beijing 100049, China

3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xi Zhang

1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yinglei Gao

2University of Chinese Academy of Sciences, Beijing 100049, China

3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jian Ding

2University of Chinese Academy of Sciences, Beijing 100049, China

3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: [email protected] [email protected]

Linghua Meng

1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2University of Chinese Academy of Sciences, Beijing 100049, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: [email protected] [email protected]

Article
Figures & Data
Info & Metrics
References
PDF

References

1.↵
2. Wang YX,
3. Li X,
4. Liu XL,
5. Chen Y,
6. Yang CH,
7. Tan C, et al.
Simultaneous inhibition of pi3k alpha and cdk4/6 synergistically suppresses kras-mutated non-small cell lung cancer. Cancer Biol Med 2019; 16: 66–83.
OpenUrl Abstract/FREE Full Text

PreviousNext

In this issue

Cancer Biology & Medicine

Vol. 16, Issue 4

1 Nov 2019

Table of Contents
Index by author

Download PDF

Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Message Subject (Your Name) has sent you a message from Cancer Biology & Medicine

Message Body (Your Name) thought you would like to see the Cancer Biology & Medicine web site.

Your Personal Message

Citation Tools

Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding, Linghua Meng

Cancer Biology & Medicine Nov 2019, 16 (4) 836; DOI: 10.20892/j.issn.2095-3941.2019.0401

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding, Linghua Meng

Cancer Biology & Medicine Nov 2019, 16 (4) 836; DOI: 10.20892/j.issn.2095-3941.2019.0401

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
- References
Figures & Data
Info & Metrics
References
PDF

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

[1] 1.↵

Wang YX,
Li X,
Liu XL,
Chen Y,
Yang CH,
Tan C, et al.
Simultaneous inhibition of pi3k alpha and cdk4/6 synergistically suppresses kras-mutated non-small cell lung cancer. Cancer Biol Med 2019; 16: 66–83.
OpenUrl Abstract/FREE Full Text

[3] Wang YX,

[4] Li X,

[5] Liu XL,

[6] Chen Y,

[7] Yang CH,

[8] Tan C, et al.

Main menu

User menu

Search

Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

For Authors

Journal Services